[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100522192":3},{"organization":4,"armGroups":7,"interventions":14,"overallOfficials":20,"centralContacts":24,"locations":32,"responsibleParty":53,"collaborators":10,"id":55,"slug":10,"hasResults":56,"nctId":57,"briefTitle":58,"officialTitle":59,"acronym":60,"eligibilityCriteria":61,"healthyVolunteers":62,"sex":63,"minAge":64,"maxAge":65,"enrollmentInfo":66,"targetDuration":10,"studyType":69,"phases":10,"briefSummary":70,"conditions":71,"keywords":73,"overallStatus":35,"whyStopped":10,"lastUpdateSubmitDate":77,"lastUpdatePostDateStruct":78,"startDateStruct":81,"completionDateStruct":83,"leadSponsor":85,"locationsCount":86},{"fullName":5,"class":6},"Institut National de la Santé Et de la Recherche Médicale, France","OTHER_GOV",[8],{"label":9,"type":10,"description":11,"interventionNames":12},"Level of vascular aging",null,"community-based prospective longitudinal cohort",[13],"Other: high-precision carotid echo-tracking",[15],{"type":16,"name":17,"description":18,"armGroupLabels":19,"otherNames":10},"OTHER","high-precision carotid echo-tracking","evaluation of vascular aging parameters and baroreflex sensitivity",[9],[21],{"name":22,"affiliation":5,"role":23},"Jean-Philippe Empana, MD, PhD","PRINCIPAL_INVESTIGATOR",[25,29],{"name":22,"role":26,"phone":27,"phoneExt":10,"email":28},"CONTACT","33153988020","jean-philippe.empana@inserm.fr",{"name":30,"role":26,"phone":10,"phoneExt":10,"email":31},"Xavier Jouven, MD, PhD","xavier.jouven@inserm.fr",[33],{"facility":34,"status":35,"city":36,"state":10,"zip":37,"country":38,"cosmosGeoPoint":39,"geoPoint":44,"contacts":45},"Centre d'Investigation Précliniques","RECRUITING","Paris","75016","France",{"type":40,"coordinates":41},"Point",[42,43],2.3488,48.85341,{"lat":43,"lon":42},[46,50,52],{"name":47,"role":26,"phone":48,"phoneExt":10,"email":49},"Nicolas Danchin","0153673535","nicolas.danchin@egp.aphp.fr",{"name":51,"role":26,"phone":10,"phoneExt":10,"email":28},"Jean-Philippe Empana",{"name":51,"role":23,"phone":10,"phoneExt":10,"email":10},{"type":54,"investigatorFullName":10,"investigatorTitle":10,"investigatorAffiliation":10,"oldNameTitle":10,"oldOrganization":10},"SPONSOR","100522192",false,"NCT06079424","Risk Markers of Arterial Aging. The Paris Prospective Study III-2","Risk Markers of Arterial Aging and Subsequent Risk of Cardiovascular Diseases and Beyond. The Paris Prospective Study III-2","PPS3-2","Inclusion Criteria:\n\n* Being enrolled in PPS3 and having signed an informed consent for PPS3-2\n\nExclusion Criteria:\n\n* Institutionalized participants\n* Participants under guardianship\n* Participants under judicial safeguard measure",true,"ALL","60 Years","95 Years",{"count":67,"type":68},7500,"ESTIMATED","OBSERVATIONAL","The main objectives of PPS3-2 are (i) to describe the dynamics of vascular aging and baroreflex sensitivity 12 to 16 years a part, (ii) to identify their determinants, and (iii) to quantify the subsequent risk of cardiovascular diseases.",[72],"Arterial Stiffness",[74,75,76],"risk factors","cohort","cardiovascular diseases","2025-09-04",{"date":79,"type":80},"2025-09-11","ACTUAL",{"date":82,"type":80},"2025-06-20",{"date":84,"type":68},"2033-12",{"name":5,"class":6},1]